Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!


Judge strikes down restrictions on “morning after” pill

FDA must make emergency contraception pill available without a prescription to all women

Reproductive rights advocates have reason to celebrate. A Brooklyn federal judge has ordered the Food and Drug Administration (FDA) to make the “morning after” pill available to women of all ages and without a prescription.

Currently, the government enforces age restrictions on nonprescription sales of emergency contraception pills to girls who are 16 years old or younger. For more than a decade, the Center for Reproductive Rights and other advocacy groups have petitioned the FDA to strike down the restrictions, saying there is no scientific proof that girls younger than 17 couldn’t safely use the drug without supervision. Additionally, Teva Pharmaceuticals Ltd., the maker of the first nonprescription emergency contraceptive pill available in the U.S., petitioned the government to allow nonprescription sales of its Plan B One-Step without restrictions.

In 2011, the FDA determined that girls younger than 17 could safely and properly use Plan B One-Step without supervision. But Health and Human Services Secretary Kathleen Sebelius overruled the recommendation, and a few days later, the FDA also rejected the advocacy groups’ petition to lift restrictions on Plan B One-Step. In his decision, U.S. District Judge Edward Korman called Sebelius’ actions “politically motivated, scientifically unjustified, and contrary to agency precedent.” He ordered the FDA to make Plan B One-Step and its generic versions available without restrictions within 30 days.

Read the New York Times and Thomson Reuters more about the ruling.

For more InsideCounsel stories about legal battles over contraception, read:

Bayer settles claims of gallbladder injury caused by Yasmin and Yaz contraceptives

Bayer designates $1.5 billion for litigation over Yasmin and Yaz contraceptives

Court denies contraception coverage injunction

Birth control exemptions fail to stop lawsuits

Hobby Lobby loses appeal of contraception coverage

Hobby Lobby must cover morning-after pill, judge rules

Obamacare faces another lawsuit over contraception coverage

Woman sues birth control pill maker for unintended pregnancy

Ashley Post

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.